One of the most important launches for Novartis in recent years is off with a bang. Following a broad FDA approval for the adjuvant treatment of HR-positive, HER2-negative early breast cancer in ...

Apple’s iPads have long been the gold standard in the tablet industry, consistently outpacing competitors in performance, display quality, software optimization, and overall user experience.

Not every tablet needs to be packed with features. Sometimes, the essentials are all it takes, which makes tablets like the Lenovo Tab M9 all the more appealing. As a matter of fact, this Lenovo ...

Samsung Frame Pro Shuts Down The Art TV Haters! Tomsguide is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.

Learn more about how we select deals. SAVE $45: As of Feb. 4, the Amazon Fire HD 10 tablet is on sale for $94.99 at Amazon. That's a saving of 32% on the list price. If a tablet upgrade is planned ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

The Samsung Galaxy Tab S10 Ultra might be just the right tablet for you, but if you don’t need a big, water-resistant Android, you should probably just buy an iPad Pro. Other than the design ...

We may earn a commission when you buy through links on the site. A brand-new 11-inch tablet released mere a year ago coming down to just $100 in price would be a great way to start your week ...

Eli Lilly’s Verzenio is already one of its fastest-growing products, but could go up another gear following a pair of FDA approvals that expand its eligible patient population – particularly ...

Finding the best tablets can be a challenge with so many options available, each offering unique features and capabilities. Whether you're a student, professional, or tech enthusiast, the perfect ...

In particular, Lilly highlighted the momentum behind breast cancer med Verzenio and the SGLT2 inhibitor Jardiance, which generated roughly $1.6 billion and $1.2 billion in 2024’s fourth quarter ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...